385103000: Conventional release cutaneous foam (dose form)

SNOMED CT Concept\Qualifier value (qualifier value)\Pharmaceutical dose form (dose form)\Cutaneous dose form\Cutaneous foam

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1479365012 Cutaneous foam en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3541111016 Conventional release cutaneous foam en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3541112011 Conventional release cutaneous foam (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cutaneous foam	Is a	forme pharmaceutique pour usage transdermique et/ou cutané	false	Inferred relationship	Some
Cutaneous foam	Is a	A liquid dose form usually presented in a pressurised multi-dose container equipped with an applicator suitable for delivery of a foam consisting of large volumes of gas dispersed in a liquid containing active substance(s).	false	Inferred relationship	Some
Cutaneous foam	Is a	Cutaneous dose form	true	Inferred relationship	Some
Cutaneous foam	Has dose form administration method (attribute)	A method of administration of a dose form by placing or spreading on a body surface.	true	Inferred relationship	Some
Cutaneous foam	Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility.	An intended site for a dose form that is for administration by application to the skin, cutaneous wounds, nails or hair.	true	Inferred relationship	Some
Cutaneous foam	Has dose form release characteristic (attribute)	A release characteristic where a dose form displays a rate and time of release of the active substance(s) in the dose form based on their intrinsic properties.	true	Inferred relationship	Some
Cutaneous foam	Has basic dose form (attribute)	A liquid dose form usually presented in a pressurised multi-dose container equipped with an applicator suitable for delivery of a foam consisting of large volumes of gas dispersed in a liquid containing active substance(s).	true	Inferred relationship	Some
Cutaneous foam	Has dose form transformation (attribute)	No transformation	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely phenothrin 5 milligram/1 gram conventional release cutaneous foam (clinical drug)	Has manufactured dose form	True	Cutaneous foam	Inferred relationship	Some
Product containing precisely minoxidil 50 milligram/1 gram conventional release cutaneous foam (clinical drug)	Has manufactured dose form	True	Cutaneous foam	Inferred relationship	Some
Calcipotriol 50 microgram/mL cutaneous foam	Has manufactured dose form	True	Cutaneous foam	Inferred relationship	Some
Clindamycin 1% topical foam	Has manufactured dose form	False	Cutaneous foam	Inferred relationship	Some
Ibuprofen 50 mg/g cutaneous foam	Has manufactured dose form	True	Cutaneous foam	Inferred relationship	Some
Clobetasol propionate 500 microgram/g cutaneous foam	Has manufactured dose form	True	Cutaneous foam	Inferred relationship	Some
Desonide 500 microgram/mL cutaneous foam	Has manufactured dose form	True	Cutaneous foam	Inferred relationship	Some
Product containing precisely ketoconazole 20 milligram/1 milliliter conventional release cutaneous foam (clinical drug)	Has manufactured dose form	True	Cutaneous foam	Inferred relationship	Some
Betamethasone valerate 1.2 mg/mL cutaneous foam	Has manufactured dose form	True	Cutaneous foam	Inferred relationship	Some
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous foam (clinical drug)	Has manufactured dose form	True	Cutaneous foam	Inferred relationship	Some
Product containing precisely minocycline (as minocycline hydrochloride) 15 milligram/1 gram conventional release cutaneous foam (clinical drug)	Has manufactured dose form	True	Cutaneous foam	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g cutaneous foam	Has manufactured dose form	True	Cutaneous foam	Inferred relationship	Some

This concept is not in any reference sets